<VariationArchive VariationID="44737" VariationName="NM_004004.6(GJB2):c.313_326del (p.Lys105fs)" VariationType="Deletion" Accession="VCV000044737" Version="70" RecordType="classified" NumberOfSubmissions="27" NumberOfSubmitters="26" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="53904" VariationID="44737">
      <GeneList>
        <Gene Symbol="GJB2" FullName="gap junction protein beta 2" GeneID="2706" HGNC_ID="HGNC:4284" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q12.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="20187470" stop="20192938" display_start="20187470" display_stop="20192938" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="20761601" stop="20767113" display_start="20761601" display_stop="20767113" Strand="-" />
          </Location>
          <OMIM>121011</OMIM>
          <Haploinsufficiency last_evaluated="2012-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GJB2">Dosage sensitivity unlikely</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GJB2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004004.6(GJB2):c.313_326del (p.Lys105fs)</Name>
      <CanonicalSPDI>NC_000013.11:20189255:CCCTTGATGAACTTCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q12.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="20189256" stop="20189269" display_start="20189256" display_stop="20189269" variantLength="14" positionVCF="20189255" referenceAlleleVCF="CCCCTTGATGAACTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="20763395" stop="20763408" display_start="20763395" display_stop="20763408" variantLength="14" positionVCF="20763394" referenceAlleleVCF="CCCCTTGATGAACTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K105fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.20763397_20763410del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.20763397_20763410del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.20189258_20189271del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.20189258_20189271del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008358.1" sequenceAccession="NG_008358" sequenceVersion="1" change="g.8707_8720del">
            <Expression>NG_008358.1:g.8707_8720del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004004.6" sequenceAccession="NM_004004" sequenceVersion="6" change="c.313_326del" MANESelect="true">
            <Expression>NM_004004.6:c.313_326del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003995.2" sequenceAccession="NP_003995" sequenceVersion="2" change="p.Lys105fs">
            <Expression>NP_003995.2:p.Lys105fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1350" sequenceAccession="LRG_1350">
            <Expression>LRG_1350:g.8707_8720del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1350t1" sequenceAccession="LRG_1350t1">
            <Expression>LRG_1350t1:c.313_326del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1350p1" sequenceAccession="LRG_1350p1" change="p.Lys105fs">
            <Expression>LRG_1350p1:p.Lys105fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004004.6" sequenceAccession="NM_004004" sequenceVersion="6" change="c.313_326delAAGTTCATCAAGGG" MANESelect="true">
            <Expression>NM_004004.6:c.313_326delAAGTTCATCAAGGG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA172223" DB="ClinGen" />
        <XRef ID="GTR000604053" DB="Genetic Testing Registry (GTR)" />
        <XRef Type="Allelic variant" ID="121011.0034" DB="OMIM" />
        <XRef Type="rs" ID="111033253" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004004.6(GJB2):c.313_326del (p.Lys105fs) AND Autosomal recessive nonsyndromic hearing loss 1A" Accession="RCV000037836" Version="36">
        <ClassifiedConditionList TraitSetID="5610">
          <ClassifiedCondition DB="MedGen" ID="C2673759">Autosomal recessive nonsyndromic hearing loss 1A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-12-09" SubmissionCount="10">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004004.6(GJB2):c.313_326del (p.Lys105fs) AND Hearing impairment" Accession="RCV000146016" Version="17">
        <ClassifiedConditionList TraitSetID="8456">
          <ClassifiedCondition DB="MedGen" ID="C1384666">Hearing impairment</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-04-12" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004004.6(GJB2):c.313_326del (p.Lys105fs) AND not provided" Accession="RCV000080370" Version="56">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-31" SubmissionCount="10">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004004.6(GJB2):c.313_326del (p.Lys105fs) AND Rare genetic deafness" Accession="RCV000211774" Version="13">
        <ClassifiedConditionList TraitSetID="40993">
          <ClassifiedCondition DB="MedGen" ID="C5680250">Rare genetic deafness</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-05-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004004.6(GJB2):c.313_326del (p.Lys105fs) AND Hearing loss" Accession="RCV000678878" Version="9">
        <ClassifiedConditionList TraitSetID="37435">
          <ClassifiedCondition DB="MedGen" ID="C3887873">Hearing loss</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-11-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004004.6(GJB2):c.313_326del (p.Lys105fs) AND multiple conditions" Accession="RCV001004389" Version="9">
        <ClassifiedConditionList TraitSetID="9344">
          <ClassifiedCondition DB="MedGen" ID="C2673759">Autosomal recessive nonsyndromic hearing loss 1A</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2675235">Autosomal recessive nonsyndromic hearing loss 1B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004004.6(GJB2):c.313_326del (p.Lys105fs) AND Nonsyndromic genetic hearing loss" Accession="RCV001257561" Version="9">
        <ClassifiedConditionList TraitSetID="9568">
          <ClassifiedCondition DB="MedGen" ID="C5680182">Nonsyndromic genetic hearing loss</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-08-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-31" NumberOfSubmissions="27" NumberOfSubmitters="26" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10218527</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10874298</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10982180</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11551103</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12112666</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12172394</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14985372</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15146474</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15253766</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15855033</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15967879</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16379542</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22567152</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22695344</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24158611</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26896187</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27224056</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=GJB2</URL>
        </Citation>
        <DescriptionHistory Dated="2021-08-18">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9568" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9544" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nonsyndromic hearing loss and deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonsyndromic genetic deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nonsyndromic genetic hearing loss</ElementValue>
                <XRef ID="MONDO:0019497" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Non-syndromic genetic deafness</ElementValue>
                <XRef ID="87884" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19091" />
                <XRef ID="19091" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6410" />
                <XRef ID="6410" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng98</URL>
                <CitationText>UK NICE Guideline (NG98), Hearing loss in adults: assessment and management, 2023</CitationText>
              </Citation>
              <XRef ID="87884" DB="Orphanet" />
              <XRef ID="C5680182" DB="MedGen" />
              <XRef ID="MONDO:0019497" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="40993" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38576" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rare genetic deafness</ElementValue>
                <XRef ID="96210" DB="Orphanet" />
              </Name>
              <XRef ID="96210" DB="Orphanet" />
              <XRef ID="C5680250" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="37435" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="38235" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Hearing loss</ElementValue>
                <XRef ID="C35731" DB="NCI" />
              </Name>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/Hearing-Loss-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics ACT SHEET, Newborn Screening ACT Sheet Algorithm, Congenital Hearing Loss, 2009</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng98</URL>
                <CitationText>UK NICE Guideline (NG98), Hearing loss in adults: assessment and management, 2023</CitationText>
              </Citation>
              <XRef ID="C3887873" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5610" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="946" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GJB6-Related DFNB 1 Nonsyndromic Hearing Loss and Deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal recessive 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DFNB 1 Nonsyndromic Hearing Loss and Deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive nonsyndromic hearing loss 1A</ElementValue>
                <XRef ID="MONDO:0009076" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Connexin 26 deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness nonsyndromic, Connexin 26 linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonsyndromic Hearing Loss and Deafness, DFNB1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DFNB1A</ElementValue>
                <XRef Type="MIM" ID="220290" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DFNB1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">GJB2-related deafness</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Nonsyndromic hearing loss and deafness (DFNB1) is characterized by congenital non-progressive mild-to-profound sensorineural hearing impairment. No other associated medical findings are present.</Attribute>
                <XRef ID="NBK1272" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1697" />
                <XRef ID="1697" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301449</ID>
                <ID Source="BookShelf">NBK1272</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301607</ID>
                <ID Source="BookShelf">NBK1434</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2009">
                <URL>https://www.nice.org.uk/guidance/ta166</URL>
                <CitationText>National Institute for Health and Clinical Excellence, Cochlear implants for children and adults with severe to profound deafness, 2009 [See 2019 Update, TA566]</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/TA566</URL>
                <CitationText>Cochlear implants for children and adults with severe to profound deafness (2019 Update)</CitationText>
              </Citation>
              <XRef ID="90636" DB="Orphanet" />
              <XRef ID="C2673759" DB="MedGen" />
              <XRef ID="MONDO:0009076" DB="MONDO" />
              <XRef Type="MIM" ID="220290" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9344" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="946" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GJB6-Related DFNB 1 Nonsyndromic Hearing Loss and Deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal recessive 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DFNB 1 Nonsyndromic Hearing Loss and Deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive nonsyndromic hearing loss 1A</ElementValue>
                <XRef ID="MONDO:0009076" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Connexin 26 deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness nonsyndromic, Connexin 26 linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonsyndromic Hearing Loss and Deafness, DFNB1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DFNB1A</ElementValue>
                <XRef Type="MIM" ID="220290" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DFNB1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">GJB2-related deafness</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Nonsyndromic hearing loss and deafness (DFNB1) is characterized by congenital non-progressive mild-to-profound sensorineural hearing impairment. No other associated medical findings are present.</Attribute>
                <XRef ID="NBK1272" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1697" />
                <XRef ID="1697" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301449</ID>
                <ID Source="BookShelf">NBK1272</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301607</ID>
                <ID Source="BookShelf">NBK1434</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2009">
                <URL>https://www.nice.org.uk/guidance/ta166</URL>
                <CitationText>National Institute for Health and Clinical Excellence, Cochlear implants for children and adults with severe to profound deafness, 2009 [See 2019 Update, TA566]</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/TA566</URL>
                <CitationText>Cochlear implants for children and adults with severe to profound deafness (2019 Update)</CitationText>
              </Citation>
              <XRef ID="90636" DB="Orphanet" />
              <XRef ID="C2673759" DB="MedGen" />
              <XRef ID="MONDO:0009076" DB="MONDO" />
              <XRef Type="MIM" ID="220290" DB="OMIM" />
            </Trait>
            <Trait ID="1229" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal recessive 1b</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive nonsyndromic hearing loss 1B</ElementValue>
                <XRef ID="MONDO:0012977" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DFNB1B</ElementValue>
                <XRef Type="MIM" ID="612645" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GJB6</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22629" />
                <XRef ID="22629" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="90636" DB="Orphanet" />
              <XRef ID="C2675235" DB="MedGen" />
              <XRef ID="MONDO:0012977" DB="MONDO" />
              <XRef Type="MIM" ID="612645" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8456" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="17089" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Hearing impairment</ElementValue>
                <XRef ID="HP:0000365" DB="Human Phenotype Ontology" />
              </Name>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24651602</ID>
              </Citation>
              <XRef ID="C1384666" DB="MedGen" />
              <XRef ID="MONDO:0005365" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000365" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0000404" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001728" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001729" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001754" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008560" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008563" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="341003" SubmissionDate="2014-09-11" DateLastUpdated="2014-11-23" DateCreated="2014-11-23">
        <ClinVarSubmissionID localKey="NM_004004.5(GJB2):c.313_326del" />
        <ClinVarAccession Accession="SCV000193167" DateUpdated="2014-11-23" DateCreated="2014-11-23" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2007</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">18414213</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" start="20763395" />
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="111033253" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <Name>
              <ElementValue Type="Preferred">Hearing impairment</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN000341" Type="CUI" />
            <XRef DB="HP" ID="HP:0000365" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="962397" SubmissionDate="2016-11-12" DateLastUpdated="2014-11-23" DateCreated="2014-11-23">
        <ClinVarSubmissionID localKey="CMGVARID00307|HPO:HP:0000365" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000492741" DateUpdated="2014-11-23" DateCreated="2014-11-23" Type="SCV" Version="1" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-01-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326delAAGTTCATCAAGGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0000365" />
          </Trait>
        </TraitSet>
        <StudyDescription>Diagnostic exome sequencing variant classification from diagnostic exome sequencing programme</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>CMG_Slovenia_Submission_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1569952" SubmissionDate="2018-07-17" DateLastUpdated="2018-09-14" DateCreated="2018-09-14">
        <ClinVarSubmissionID localKey="NM_004004.5:c.313_326del|MedGen:C3887873" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000805071" DateUpdated="2018-09-14" DateCreated="2018-09-14" Type="SCV" Version="1" SubmitterName="Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital" OrgID="1027" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-11-13">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <Name>
              <ElementValue Type="Preferred">Hearing loss</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C3887873" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4286518</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1372805" SubmissionDate="2017-06-30" DateLastUpdated="2019-07-31" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="3537_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000700403" DateUpdated="2019-07-31" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000227314" DateChanged="2019-08-06" Version="4">
            <Comment Type="MergeComment">SCV000227314 was merged into SCV000700403 to remove duplication.</Comment>
          </Replaced>
          <Replaced Accession="SCV000112266" DateChanged="2018-02-14" Version="3" />
        </ReplacedList>
        <Classification DateLastEvaluated="2015-02-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation>
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="10" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="10" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="-" referenceAllele="CCCTTGATGAACTT" start="20763395" stop="20763408" variantLength="14" />
            <GeneLocation>NM_004004.5:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD991732" />
            <XRef DB="dbSNP" ID="111033253" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=GJB2</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL005</SubmissionName>
          <SubmissionName>PILOT_TEST_03</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2292417" SubmissionDate="2019-09-27" DateLastUpdated="2020-02-29" DateCreated="2020-02-29">
        <ClinVarSubmissionID localKey="NC_000013.10:g.20763397_20763410delCTTGATGAACTTCC|OMIM:220290;612645" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001163361" DateUpdated="2020-02-29" DateCreated="2020-02-29" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.20763397_20763410delCTTGATGAACTTCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220290" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612645" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BG_GA_2018_SNVs_INDELS</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="38814" SubmissionDate="2020-05-06" DateLastUpdated="2020-05-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="121011.0034_DEAFNESS, AUTOSOMAL RECESSIVE 1A" title="GJB2, 14-BP DEL, NT313_DEAFNESS, AUTOSOMAL RECESSIVE 1A" />
        <ClinVarAccession Accession="SCV000038814" DateUpdated="2020-05-09" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 5 of 156 Czech patients with prelingual deafness (DFNB1A; 220290), Seeman et al. (2004) identified a 14-bp deletion at nucleotide 313 of the GJB2 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">15253766</ID>
              </Citation>
              <XRef DB="OMIM" ID="220290" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <Name>GJB2, 14-BP DEL, NT313</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">14-BP DEL, NT313</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="121011.0034" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DEAFNESS, AUTOSOMAL RECESSIVE 1A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354461" SubmissionDate="2020-06-18" DateLastUpdated="2020-07-03" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="23073|OMIM:220290" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194006" DateUpdated="2020-07-03" DateCreated="2020-04-06" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000678003" DateChanged="2020-07-02" Version="1">
            <Comment Type="MergeComment">SCV000678003 was merged into SCV001194006 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2019-12-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22567152</ID>
          </Citation>
          <Comment>NM_004004.5(GJB2):c.313_326del14(K105Gfs*5) is classified as pathogenic in the context of GJB2-related DFNB1 nonsyndromic hearing loss and deafness. Sources cited for classification include the following: PMID 22567152. Classification of NM_004004.5(GJB2):c.313_326del14(K105Gfs*5) is based on the following criteria: The variant causes a premature termination codon that is not expected to be targeted by nonsense-mediated mRNA decay; however, literature evidence strongly supports pathogenicity. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="C" referenceAllele="CCCCTTGATGAACTT" start="20763394" stop="20763408" variantLength="15" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220290" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
          <SubmissionName>SUB7605676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2868613" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_004004.6:c.313_326delAAGTTCATCAAGGG|Autosomal recessive deafness type 1A" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001453338" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.6:c.313_326delAAGTTCATCAAGGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Autosomal recessive deafness type 1A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1197166" SubmissionDate="2021-09-13" DateLastUpdated="2021-09-19" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="NM_004004.5:c.313_326del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000613512" DateUpdated="2021-09-19" DateCreated="2016-12-06" Type="SCV" Version="2" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26896187</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15253766</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12112666</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15967879</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15146474</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27224056</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10218527</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene. In multiple individuals, this variant has been seen with a single recessive pathogenic variant in the same gene, suggesting this variant may also be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10229685</SubmissionName>
          <SubmissionName>SUB2963629</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3878238" SubmissionDate="2021-10-04" DateLastUpdated="2021-10-30" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="NM_004004.6:c.313_326delAAGTTCATCAAGGG|OMIM:220290" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001984287" DateUpdated="2021-10-30" DateCreated="2021-10-30" Type="SCV" Version="1" SubmitterName="Al Jalila Childrens Genomics Center, Al Jalila Childrens Speciality Hospital" OrgID="507199" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-25">
          <ReviewStatus>flagged submission</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.6:c.313_326delAAGTTCATCAAGGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220290" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>The p.Lys105fs variant in GJB2 is a well-established pathogenic variant that has been reported in the homozygous or compound heterozygous states with other known pathogenic variants in several individuals with hearing loss (PMIDs: 9529365 15967879 26896187). It has also been identified in 27/128614 (0.02% 0 homozygotes) European Non-Finnish alleles in the Genome Aggregation Database (gnomAD). This variant is specifically high in the Lithuanian population where its carrier frequency in this population is 2% accounting for 28% of all pathogenic GJB2 variants in hearing loss patients of this population (PMID: 26896187). This frameshift variant is predicted to alter the protein's amino acid sequence beginning at position 105 and lead to a premature termination codon 5 amino acids downstream. This variant is classified as pathogenic by several clinical laboratories (ClinVar ID: 44737). In summary this variant meets our criteria for pathogenicity.</Comment>
        <Comment DataSource="NCBI" Type="FlaggedComment">Reason: This record appears to be redundant with a more recent record from the same submitter.</Comment>
        <Comment DataSource="NCBI" Type="FlaggedComment">Notes: SCV001984287 appears to be redundant with SCV002818209.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB10465084</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5502692" SubmissionDate="2022-12-17" DateLastUpdated="2023-01-07" DateCreated="2023-01-07">
        <ClinVarSubmissionID localKey="NM_004004.5:c.313_326del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002818209" DateUpdated="2023-01-07" DateCreated="2023-01-07" Type="SCV" Version="1" SubmitterName="Al Jalila Childrens Genomics Center, Al Jalila Childrens Speciality Hospital" OrgID="507199" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12445851</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7905176" SubmissionDate="2024-01-18" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="SUB14155996" submittedAssembly="GRCh37" title="SUB14155996" />
        <ClinVarAccession Accession="SCV004231803" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Clinical Genomics Laboratory, Stanford Medicine" OrgID="507411" OrganizationCategory="laboratory" OrgAbbreviation="CGP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-24">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.Lys105Glyfs*5 variant in the GJB2 gene is a well reported cause of nonsyndromic hearing loss. This variant was determined to be in trans with other pathogenic variants (p.Gly12Valfs*2, p.Met34Thr), consistent with autosomal recessive inheritance (Marlin et al., 2005; Mikstiene et al., 2016). The presence of this variant with an established disease-causing variant on the opposite allele increases suspicion for its pathogenicity. The p.Lys105Glyfs*5 variant has also been identified in 9/30,614 South Asian chromosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org/). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant results in a 14 bp deletion, which causes a shift in the protein reading frame, leading to a premature termination codon 5 amino acids downstream. Loss of function is an established mechanism of disease for the GJB2 gene. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, there is sufficient evidence to classify the p.Lys105Glyfs*5 variant as pathogenic for autosomal recessive nonsyndromic hearing loss based on the information above. [ACMG evidence codes used: PVS1; PM3_verystrong; PM2_supporting]</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB3">
              <Name>gap junction protein beta 3</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Lys105Glyfs*5</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220290" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14155996</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2467242" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-09">
        <ClinVarSubmissionID localKey="100979|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001245650" DateUpdated="2024-07-15" DateCreated="2020-05-09" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>GJB2: PM3:Very Strong, PVS1, PM2</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="7" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="C" referenceAllele="CCCCTTGATGAACTT" start="20763394" stop="20763408" variantLength="15" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1162846" SubmissionDate="2017-05-17" DateLastUpdated="2017-09-19" DateCreated="2017-09-19">
        <ClinVarSubmissionID localKey="GJB2-25|OMIM:220290" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000599744" DateUpdated="2017-09-19" DateCreated="2017-09-19" Type="SCV" Version="1" SubmitterName="Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia" OrgID="165021" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">DGD Variant Analysis Guidelines</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="3" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Lys105Glyfs*5</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Deafness, autosomal recessive 1A</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="220290" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GJB2_submission</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1364597" SubmissionDate="2018-01-25" DateLastUpdated="2018-01-06" DateCreated="2018-01-06">
        <ClinVarSubmissionID localKey="NM_004004.5:c.313_326delAAGTTCATCAAGGG|MedGen:C2673759" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000698245" DateUpdated="2018-01-06" DateCreated="2018-01-06" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14985372</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12172394</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12112666</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15967879</ID>
          </Citation>
          <Comment>Variant summary: The GJB2 c.313_326delAAGTTCATCAAGGG (p.Lys105Glyfs) variant (alternatively also known as 313del14, 313-326del14, or 312del14) results in a premature termination codon, predicted to cause a truncated or absent GJB2 protein due to nonsense mediated decay (NMD), which are commonly known mechanisms for disease. If NMD is escaped, this variant is expected to truncate gap junction protein, cysteine-rich domain and connexin, N-terminal domain (InterPro).Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. p.Gln124X, p.Gln164X, c.647_650delGAGA, etc.). This variant was found in 12/121692 control chromosomes at a frequency of 0.0000986, which does not exceed the estimated maximal expected allele frequency of a pathogenic GJB2 variant (0.025). This variant is recurrently reported in patients with autosomal recessive NSHL and is reported to have hearing loss less severe than the c.35delG homozygotes (Kupka_2002, Wu_2002, Cryns_2004, Marlin_2005). Multiple clinical diagnostic laboratories/reputable databases have classified this variant as pathogenic. Taken together, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="111033253" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326delAAGTTCATCAAGGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2673759" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1789680" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="1386718" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000914614" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26896187</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10218527</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22695344</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15967879</ID>
          </Citation>
          <Comment>The GJB2 c.313_326delAAGTTCATCAAGGG (p.Lys105GlyfsTer5) variant results in a frameshift and is predicted to result in premature termination of the protein. Across a selection of the available literature, the p.Lys105GlyfsTer5 variant has been identified in a total of 59 individuals with autosomal recessive nonsyndromic hearing loss including 18 homozygotes and 41 compound heterozygotes (Denoyelle et al. 1999; Marlin et al. 2005; Bazazzadegan et al 2012; Mikstiene et al. 2016). Thirty-seven of the compound heterozygotes carry c.35delG, a well known pathogenic variant, on the second allele. The p.Lys105GlyfsTer5 variant was found in a heterozygous state in two control individuals and is reported at a frequency of 0.00032 in the South Asian population of the Genome Aggregation Database. Based on the collective evidence and potential impact of frameshift variants, the p.Lys105GlyfsTer5 variant is classified as pathogenic for autosomal recessive nonsyndromic hearing loss. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="C" referenceAllele="CCCCTTGATGAACTT" start="20763394" stop="20763408" variantLength="15" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326delAAGTTCATCAAGGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220290" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="102698" SubmissionDate="2019-03-21" DateLastUpdated="2018-04-09" DateCreated="2013-05-03">
        <ClinVarSubmissionID localKey="11612933|Orphanet:ORPHA96210" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000061498" DateUpdated="2018-04-09" DateCreated="2013-05-03" Type="SCV" Version="5" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15253766</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12112666</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11551103</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16379542</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15146474</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15967879</ID>
          </Citation>
          <Comment>The p.Lys105fs variant in GJB2 is a well-known pathogenic variant and has been i dentified in many individuals with hearing loss who were homozygous or compound heterozygous with another pathogenic variant in GJB2 (Marlin 2005). It has been reported in 27/126134 European chromosomes and 10/20780 South Asian chromosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org/; dbSNP rs1 99976861). This frequency in the general population is consistent with the carri er frequency for autosomal recessive hearing loss. This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 105 and leads to a premature termination codon 5 amino acids downstream . In summary, this variant meets criteria to be classified as pathogenic for aut osomal recessive hearing loss based on the predicted impact to the protein and m ultiple previously reported affected compound heterozygotes. ACMG/AMP Criteria a pplied: PVS1, PM3_VeryStrong.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="14" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="17" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_004004.5:EXON 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_004004.5:c.313_326del</Name>
            <Name>p.Lys105fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.20763395_20763408del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA96210" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348977</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5041298" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_004004.6:c.313_326del|OMIM:220290" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002579735" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="111033253" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.6:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220290" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PM3_STR, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1167526" SubmissionDate="2022-04-30" DateLastUpdated="2022-12-24" DateCreated="2017-09-30">
        <ClinVarSubmissionID localKey="86758|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000603830" DateUpdated="2022-12-24" DateCreated="2017-09-30" Type="SCV" Version="5" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The GJB2 c.313_326del; p.Lys105GlyfsTer5 variant (rs111033253) is reported in the literature in individuals affected with hearing loss, both in the homozygous state and in trans to other pathogenic variants (Dalamon 2013, Denoyelle 1999, Kupa 2002, Mikstiene 2016). This variant is reported as pathogenic by numerous laboratories in ClinVar (Variation ID: 44737) and it is found in the general population with an overall allele frequency of 0.01% (38/281690 alleles) in the Genome Aggregation Database. This variant causes a frameshift by deleting 14 nucleotides, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, the c.313_326del variant is considered to be pathogenic. References: Dalamon V et al. Identification of four novel connexin 26 mutations in non-syndromic deaf patients: genotype-phenotype analysis in moderate cases. Mol Biol Rep. 2013 Dec;40(12):6945-55. PMID: 24158611. Denoyelle F et al. Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling. Lancet. 1999 Apr 17;353(9161):1298-303. PMID: 10218527. Kupka S et al. Frequencies of GJB2 mutations in German control individuals and patients showing sporadic non-syndromic hearing impairment. Hum Mutat. 2002 Jul;20(1):77-8. PMID: 12112666. Mikstiene V et al. The high frequency of GJB2 gene mutation c.313_326del14 suggests its possible origin in ancestors of Lithuanian population. BMC Genet. 2016 Feb 19;17:45. PMID: 26896187.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ythvkvge/arup_molecular_germline_variant_investigation_process_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.20763397_20763410delCTTGATGAACTTCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2020 ARUP</SubmissionName>
          <SubmissionName>May 2022</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="643210" SubmissionDate="2021-10-27" DateLastUpdated="2023-03-04" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDXSV:187547" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000329860" DateUpdated="2023-03-04" DateCreated="2016-12-06" Type="SCV" Version="8" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation, as the last 122 amino acids are lost and replaced with 4 incorrect amino acids (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 22975760, 30094485, 10218527, 27224056, 25999548, 22567152, 29701678, 30168495, 30344259, 9529365, 29625052, 31980526, 31160754, 33096615, 31589614, 32067424, 26896187)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:729575</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_63_20211027054205</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7897965" SubmissionDate="2023-12-21" DateLastUpdated="2024-01-06" DateCreated="2024-01-06">
        <ClinVarSubmissionID localKey="1633631|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004225744" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12112666</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15967879</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26896187</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27224056</ID>
          </Citation>
          <Comment>PM2_supporting, PM3_very_strong, PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_004004.5:exon 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Lys105Glyfs*5</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3967905" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="906d8cef6a941bf0aa651795dc8519c48ca4ca29e72e55488bc0f4a7c0ecb27d|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002024256" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.6:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2392901" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4911937|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001227363" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10218527</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22567152</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26896187</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27224056</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10874298</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10982180</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15855033</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25708704</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys105Glyfs*5) in the GJB2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 122 amino acid(s) of the GJB2 protein. This variant is present in population databases (rs111033253, gnomAD 0.03%). This premature translational stop signal has been observed in individuals with autosomal recessive deafness (PMID: 10218527, 22567152, 26896187, 27224056). ClinVar contains an entry for this variant (Variation ID: 44737). This variant disrupts the p.Pro173, p.Arg184 amino acid residue in GJB2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10874298, 10982180, 15855033, 25708704). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.20763395_20763408del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2832647" SubmissionDate="2020-09-22" DateLastUpdated="2020-10-02" DateCreated="2020-10-02">
        <ClinVarSubmissionID localKey="NM_004004.6:c.313_326del|MedGen:CN043648" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001434015" DateUpdated="2020-10-02" DateCreated="2020-10-02" Type="SCV" Version="1" SubmitterName="INGEBI, INGEBI / CONICET" OrgID="506957" OrganizationCategory="laboratory" OrgAbbreviation="INGEBI" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10218527</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10982180</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11551103</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24158611</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27224056</ID>
          </Citation>
          <Comment>Based on ACMG/AMP guidelines and Hearing Loss Expert Panel specific criteria: the filtering allele frequency of the c.313_326del (p.Lys105fs*5) variant in the GJB2 gene is 0,015% (9/30614 South Asian alleles with 95% CI) in Genome Aggregation Database (http://gnomad.broadinstitute.org; calculated by using inverse allele frequency at https://www.cardiodb.org/allelefrequencyapp/), which meets the PM2_Supporting criteria. The c.313_326del variant is predicted to cause a premature stop codon in the only exon of GJB2 that leads to a truncated or absent protein in a gene in which loss-of-function is an established mechanism (PVS1). This variant has been detected in trans with at least 4 pathogenic variants in different hearing loss patients (PMID: 10218527, 10982180, 11551103, 24158611, 27224056) applying to PM3_VeryStrong. This variant meets criteria to be classified as pathogenic for autosomal recessive non-syndromic hearing loss: PM2_Supporting, PVS1, PM3_VeryStrong.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen HL ACMG Specifications v1</Attribute>
          <Citation>
            <ID Source="PubMed">30311386</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Caucasian</Ethnicity>
              <GeographicOrigin>Argentina</GeographicOrigin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
              <FamilyData NumFamiliesWithVariant="2">
                <FamilyHistory>no</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <TypePlatform>Sanger Sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Prelingual moderate bilateral hearing loss</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="111033253" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.6:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Nonsyndromic hearing loss and deafness</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN043648" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8189606</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2862741" SubmissionDate="2020-11-26" DateLastUpdated="2020-12-10" DateCreated="2020-12-10">
        <ClinVarSubmissionID localKey="NM_004004.6:c.313_326del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001449875" DateUpdated="2020-12-10" DateCreated="2020-12-10" Type="SCV" Version="1" SubmitterName="Clinical Genetics and Genomics, Karolinska University Hospital" OrgID="505315" OrganizationCategory="laboratory" OrgAbbreviation="KLINGEN-KUS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.6:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8639822</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3095196" SubmissionDate="2021-08-17" DateLastUpdated="2021-08-21" DateCreated="2021-05-01">
        <ClinVarSubmissionID localKey="NM_004004.5:c.313_326del|HPO:HP:0000365" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001571779" DateUpdated="2021-08-21" DateCreated="2021-05-01" Type="SCV" Version="2" SubmitterName="Department of Otolaryngology  Head &amp; Neck Surgery, Cochlear Implant Center" OrgID="508028" OrganizationCategory="clinic" OrgAbbreviation="HNO" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26896187</ID>
          </Citation>
          <Comment>PVS1_Strong, PM2_Moderate, PM3_Moderate</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen HL ACMG Specifications v1</Attribute>
          <Citation>
            <ID Source="PubMed">30311386</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.313_326del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0000365" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10202264</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3672047" SubmissionDate="2021-09-09" DateLastUpdated="2021-09-19" DateCreated="2021-09-19">
        <ClinVarSubmissionID localKey="13:20189255" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001870363" DateUpdated="2021-09-19" DateCreated="2021-09-19" Type="SCV" Version="1" SubmitterName="HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology" OrgID="505530" OrganizationCategory="laboratory" OrgAbbreviation="HA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG codes:PVS1, PM2, PP5</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">13:20189255:I-00163-C</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0008619" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0007018" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000494" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.6:c.313_326delAAGTTCATCAAGGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220290" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>AGHI WGS</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10356128</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1372805" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="643210" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3672047" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="102698" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA96210" MappingRef="Orphanet">
        <MedGen CUI="C5680250" Name="Rare genetic deafness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1197166" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="962397" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000365" MappingRef="HP">
        <MedGen CUI="C1384666" Name="Hearing impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3672047" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008619" MappingRef="HP">
        <MedGen CUI="C0452138" Name="Bilateral sensorineural hearing impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="38814" TraitType="Disease" MappingType="Name" MappingValue="DEAFNESS, AUTOSOMAL RECESSIVE 1A" MappingRef="Preferred">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7905176" TraitType="Disease" MappingType="XRef" MappingValue="220290" MappingRef="OMIM">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1162846" TraitType="Disease" MappingType="Name" MappingValue="Deafness, autosomal recessive 1A" MappingRef="Preferred">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2832647" TraitType="Disease" MappingType="Name" MappingValue="Nonsyndromic hearing loss and deafness" MappingRef="Preferred">
        <MedGen CUI="C5680182" Name="Nonsyndromic genetic hearing loss" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1167526" TraitType="Disease" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2868613" TraitType="Disease" MappingType="Name" MappingValue="Autosomal recessive deafness type 1A" MappingRef="Preferred">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1789680" TraitType="Disease" MappingType="XRef" MappingValue="220290" MappingRef="OMIM">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3672047" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000494" MappingRef="HP">
        <MedGen CUI="C0423110" Name="Downslanted palpebral fissures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1569952" TraitType="Finding" MappingType="Name" MappingValue="Hearing loss" MappingRef="Preferred">
        <MedGen CUI="C3887873" Name="Hearing loss" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2292417" TraitType="Disease" MappingType="XRef" MappingValue="612645" MappingRef="OMIM">
        <MedGen CUI="C2675235" Name="Autosomal recessive nonsyndromic hearing loss 1B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3095196" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000365" MappingRef="HP">
        <MedGen CUI="C1384666" Name="Hearing impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3967905" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5502692" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="341003" TraitType="Finding" MappingType="Name" MappingValue="Hearing impairment" MappingRef="Preferred">
        <MedGen CUI="C1384666" Name="Hearing impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2392901" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2862741" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2292417" TraitType="Disease" MappingType="XRef" MappingValue="220290" MappingRef="OMIM">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1364597" TraitType="Disease" MappingType="XRef" MappingValue="C2673759" MappingRef="MedGen">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7897965" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3672047" TraitType="Disease" MappingType="XRef" MappingValue="220290" MappingRef="OMIM">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3878238" TraitType="Disease" MappingType="XRef" MappingValue="220290" MappingRef="OMIM">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5041298" TraitType="Disease" MappingType="XRef" MappingValue="220290" MappingRef="OMIM">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3672047" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007018" MappingRef="HP">
        <MedGen CUI="C1263846" Name="Attention deficit hyperactivity disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2832647" TraitType="Finding" MappingType="Name" MappingValue="Prelingual moderate bilateral hearing loss" MappingRef="Preferred">
        <MedGen CUI="None" Name="Prelingual moderate bilateral hearing loss" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354461" TraitType="Disease" MappingType="XRef" MappingValue="220290" MappingRef="OMIM">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2467242" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

